How did Trinity Biotech's revenue and expenses shift in Q3 2024?
4/14/2025 03:19pm
Trinity Biotech experienced a significant shift in its financial performance during Q3 2024, with total revenue amounting to $15.15 million and total expenses amounting to -$4.76 million.
|code|Ticker|Name|Date|Cost of Goods Sold|Total Revenue|Net Income|market_code|
|---|---|---|---|---|---|---|---|
|TRIB|TRIB.O|Trinity Biotech|2023 Q4|8861000|1.3428E7|-5502000|185|
|TRIB|TRIB.O|Trinity Biotech|2024 Q1|9182000|1.4704E7|-3317000|185|
|TRIB|TRIB.O|Trinity Biotech|2024 Q2|1.0109E7|1.5843E7|-6757000|185|
|TRIB|TRIB.O|Trinity Biotech|2024 Q3|9844000|1.5152E7|-4759000|185|